Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bumrungrad Hospital PCLBUGDF 98 3-Year FCF Growth Rate is 7.20% as of Jun. 2026, which is 54% below its 10-year median of 15.70. GuruFocus rates BUGDF with a GF Score™ of 98/100 and a GF Value™ of $4.77. The stock has 3 warning signs investors should review. Among 465 Healthcare Providers & Services companies, Bumrungrad Hospital PCL ranks worse than 55.27% on this metric.
During the past 12 months, Bumrungrad Hospital PCL's average Free Cash Flow per Share Growth Rate was -32.90% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 7.20% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 37.40% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was 9.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Bumrungrad Hospital PCL was 206.20% per year. The lowest was -66.00% per year. And the median was 15.70% per year.
Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.
Bumrungrad Hospital PCL 3-Year FCF Growth Rate Related Terms
BUGDF vs HCA, THC, EHC: 3-Year FCF Growth Rate Comparison
For the Medical Care Facilities subindustry, Bumrungrad Hospital PCL's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bumrungrad Hospital PCL 3-Year FCF Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bumrungrad Hospital PCL's 3-Year FCF Growth Rate distribution charts can be found below:
* The bar in red indicates where Bumrungrad Hospital PCL's 3-Year FCF Growth Rate falls into.
This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
Bumrungrad Hospital PCL (BUGDF) has a 3-Year FCF Growth Rate of 7.20% as of Jun. 2026. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Bumrungrad Hospital PCL and its competitors. This is 54% below median its historical median of 15.70. According to the industry distribution chart, Bumrungrad Hospital PCL ranks #257 out of 465 companies in the Healthcare Providers & Services industry, placing it in the top 55.3%.
Is Bumrungrad Hospital PCL's 3-Year FCF Growth Rate too high?
Bumrungrad Hospital PCL's current 3-Year FCF Growth Rate of 7.20% is 54% below median its 10-year median of 15.70. The Healthcare Providers & Services industry median 3-Year FCF Growth Rate is 12.30. Bumrungrad Hospital PCL's value of 7.20% is 41.5% below this industry median. Based on the distribution chart, Bumrungrad Hospital PCL ranks #257 out of 465 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Bumrungrad Hospital PCL has a GF Score™ of 98/100, reflecting its overall financial health beyond just this single metric.
How does Bumrungrad Hospital PCL's 3-Year FCF Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bumrungrad Hospital PCL ranks #257 out of 465 companies for 3-Year FCF Growth Rate. This places Bumrungrad Hospital PCL in the lower half of its industry. The industry median 3-Year FCF Growth Rate is 12.30. Bumrungrad Hospital PCL's value of 7.20% is 41.5% below this benchmark. While the company's 10-year median is 15.70 vs. the industry median of 12.30, Bumrungrad Hospital PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year FCF Growth Rate for a Healthcare Providers & Services company?
The median 3-Year FCF Growth Rate among Healthcare Providers & Services companies is 12.30, based on 465 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year FCF Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year FCF Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bumrungrad Hospital PCL's current 3-Year FCF Growth Rate of 7.20% is 41.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year FCF Growth Rate mean?
A high 3-Year FCF Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Bumrungrad Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median 3-Year FCF Growth Rate is 12.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bumrungrad Hospital PCL's current 3-Year FCF Growth Rate is 7.20%, which is 54% below median its own 10-year median of 15.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bumrungrad Hospital PCL stock overvalued right now?
Bumrungrad Hospital PCL (BUGDF) has a current 3-Year FCF Growth Rate of 7.20%. The stock's GF Value™ is $4.77, compared to a current price of $4.75 — trading 0.4% below its estimated fair value. The current 3-Year FCF Growth Rate is 7.20%, which is 54% below median its 10-year median of 15.70 and 41.5% below the Healthcare Providers & Services industry median of 12.30. Bumrungrad Hospital PCL's overall GF Score™ is 98/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year FCF Growth Rate calculated?
3-Year FCF Growth Rate is calculated from a company's financial statements. For Bumrungrad Hospital PCL (BUGDF), the current 3-Year FCF Growth Rate is 7.20% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bumrungrad Hospital PCL (BUGDF) Overvalued in 2026?
Based on GuruFocus' analysis, Bumrungrad Hospital PCL stock appears to be undervalued.
The current stock price of $4.75 is trading 0.4% below its estimated GF Value™ of $4.77.
Key valuation signals for BUGDF:
3-Year FCF Growth Rate: 7.20% (54% below median its 10-year median of 15.70)
GF Value™: $4.77 vs. price of $4.75 (0.4% below fair value)
Industry Position: 41.5% below the Healthcare Providers & Services median (#257 of 465)
No single metric tells the full story. See the BUGDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bumrungrad Hospital PCL operates a private hospital business in Bangkok. The company operates several healthcare-related entities, within and outside of Thailand which include Bumrungrad International Hospital, Bumrungrad International Clinic, Vitallife Scientific Wellness Center, VitalLife Skin Clinic, Bumrungrad International Dialysis Clinic, and others. It is a healthcare provider in Thailand providing complete healthcare services for both outpatients and inpatients. The company is the owner and operator of multiple healthcare-related entities. The company has only one main reportable operating segment, which is the hospital and health care center business, and the geographical area of its operations is Thailand.
98GF Score
Get the complete analysis for BUGDF
3-Year FCF Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUGDF has been successfully added to your 
